Sonova Holding (OTCMKTS:SONVY) Short Interest Down 94.2% in June

Sonova Holding (OTCMKTS:SONVY) saw a significant decrease in short interest during the month of June. As of June 15th, there was short interest totaling 3,402 shares, a decrease of 94.2% from the May 31st total of 58,424 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 40,770 shares, the short-interest ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on SONVY shares. Jefferies Financial Group downgraded Sonova from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, March 18th. Morgan Stanley upgraded shares of Sonova from an “underweight” rating to an “equal weight” rating in a report on Tuesday. BNP Paribas Exane upgraded shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a research report on Tuesday, March 10th. Finally, Citigroup reaffirmed a “sell” rating on shares of Sonova in a report on Wednesday, May 13th. Two research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

Sonova Price Performance

Sonova stock traded down $0.12 during mid-day trading on Friday, hitting $47.93. 2,808 shares of the company were exchanged, compared to its average volume of 37,770. Sonova has a 12-month low of $42.26 and a 12-month high of $61.09. The business’s 50 day simple moving average is $48.59 and its two-hundred day simple moving average is $49.90. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.43 and a current ratio of 1.75.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.